| Term 
 
        | Aspirin, ibuprofen, NSAID's |  | Definition 
 
        | inhibit COX1 and 2--no prostaglandins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits prostaglandins only in CNS |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Celocoxib, Rofecoxib, Valdecoxib |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | local anesthetic--blocks sodium channels class I antiarrhythmic
 |  | 
        |  | 
        
        | Term 
 
        | Morphine, Codeine, Fentanyl, Heroin, Hydrocodone, Hydromorphone, meperidone, methadone, oxycodone |  | Definition 
 
        | opioid agonists (strong analgesics) |  | 
        |  | 
        
        | Term 
 
        | Pentazocine, buprenorphine, butorphanol, tramadol |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antidepressant used for neurogenic pain |  | 
        |  | 
        
        | Term 
 
        | carbamazepine, gabapentin, pregabalin |  | Definition 
 
        | anticonvulsants for neurogenic pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diuretic (antihypertensive, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diuretic (antihypertensive, CHF) |  | 
        |  | 
        
        | Term 
 
        | spironolactone (aldactone) |  | Definition 
 
        | diuretic (antihypertensive, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | depletes central and peripheral epi,norepi, dopamine (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | central acting alpha2 agonist (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | central acting alpha 2 agonist (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha1 blocker (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha1 blocker (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha1 blocker (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive, antianginal, class II antiarrhythmic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive, antianginal) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive, antianginal) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive, antianginal) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive, antianginal, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (antihypertensive, class II antiarrhythmic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha1/beta blocker and NO releasing beta blocker (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha1/beta blocker and NO releasing beta blocker (antihypertensive) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | calcium channel blocker (antihypertensive, antianginal) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | calcium channel blocker (antihypertensive, antianginal) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACE inhibitor (antihypertensive, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | angiotensin II receptor blocker (antihypertensive, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG-CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nitrate, direct vasodilator (antianginal, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | digitalis glycoside (CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-glycoside inotropic agent (CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-glycoside inotropic agent (CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta blocker (class II antiarrhythmic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | synthetic T4 (hypothyroidism) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | thionamide--inhibits iodination and coupling of iodotyrosines, type 1 deiodinase inhibitor (hyperthyroidism)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | thionamide--inhibits iodination and coupling of iodotyrosines (hyperthyroidism) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | overloads iodide transporter, inhibits release of pre-formed hormone (hyperthyroidism) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bisphosphonate (osteoporosis, Paget's Disease) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bisphosphonate (osteoporosis, Paget's Disease) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bisphosphonate (osteoporosis) |  | 
        |  | 
        
        | Term 
 
        | zoledronic acid (relclast, zometa) |  | Definition 
 
        | bisphosphonate (osteoporosis, hypercalcemia, Paget's Disease) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bone estrogen receptor agonist (postmenopausal osteoporosis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | osteoporosis, hypoparathyroidism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decreases osteoclast activity and increases Ca excretion by kidney (hypercalcemia, Paget's Disease, osteoporosis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bisphosphonate (hypercalcemia of malignancy, Paget's Disease) |  | 
        |  | 
        
        | Term 
 
        | hydrocortisone (cortisol, cortaid) |  | Definition 
 
        | short acting glucocorticoid (adrenocortical insufficiency; anti-inflammatory) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intermediate acting glucocorticoid (allergies, autoimmune disorders) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intermediate acting glucocorticoid (aersolized, topical) |  | 
        |  | 
        
        | Term 
 
        | dexamethasone (baycadron) |  | Definition 
 
        | long acting glucocorticoid (systemic anti-inflammatory) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mineralcorticoid (adrenalcortical insufficiency--addison's disease) |  | 
        |  | 
        
        | Term 
 
        | spironolactone (aldactone) |  | Definition 
 
        | competitive aldosterone antagonist (edema, hypertension, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | synthetic ACTH (diagnostic test for adrenocortical insufficiency) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiplatelet--irreversible COX inhibitor (MI, thrombosis) |  | 
        |  | 
        
        | Term 
 
        | dipyridamole (persantine) |  | Definition 
 
        | antiplatelet--phosphodiesterase inhibitor, platelet adhesion inhibitor (thrombosis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiplatelet--irreversibly binds to ADP receptor (MI, stroke, vascular death) |  | 
        |  | 
        
        | Term 
 
        | heparin (hep-lock) enoxaparin sodium (lovenox)
 |  | Definition 
 
        | anticoagulant--binds antithrombin III (venous/arterial thromboembolic disease, extracorporeal circulation, pregnancy, IV catheters) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds heparin (heparin overdose) |  | 
        |  | 
        
        | Term 
 
        | warfarin sodium (coumadin) |  | Definition 
 
        | anticoagulant--vit. K epoxide reductase inhibitor--inhibits factor II, VII, IX, X, protein C and S (venous/arterial thromboembolic disease, extracorporeal circulation, IV catheters) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anticoagulant--blocks thrombin (treatment for heparin-induced thrombocytopenia) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | fibrinolytic--cleaves plasminogen to plasmin (thrombosis, MI) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | fibrinolytic--cleaves plasminogen to plasmin (thrombosis, MI) |  | 
        |  | 
        
        | Term 
 
        | aminocaproic acid (amicar) |  | Definition 
 
        | inhibits plasmin (overactive fibrinolysis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemostatic--converts prothrombin to thrombin (hemophilia A) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemostatic--converts prothrombin to thrombin (hemophilia B) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemostatic--vit. K--required for synth of factors II, VII, IX, X (vit. K deficiency, hypoprothrombinemia, newborn hemorrhagic disease)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | iron deficiency in microcytic anemias |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | vit. B12 (cyanocabalamin, hydroxocobalamin) |  | Definition 
 
        | megaloblastic anemia, pernicious anemia |  | 
        |  | 
        
        | Term 
 
        | epoetin alfa (erythropoietin, EPO, Epogen, procrit) |  | Definition 
 
        | growth and differentiation of erythrocytes (chronic anemias--AIDS or cancer) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | growth and differentiation of neutrophils (neutropenics from chemo or HIV) |  | 
        |  | 
        
        | Term 
 
        | sargramostim (GM-CSF; leukine) |  | Definition 
 
        | growth and differentiation of granulocytes and macrophages (cancer patients or after bone marrow transplant) |  | 
        |  | 
        
        | Term 
 
        | oprelvekin (interleukin 11; neumega) |  | Definition 
 
        | growth and differentiation of megakaryocytes and platelets (thrombocytopenia in cancer patients) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 11 B-hydroxylase inhibitor--inhibits cortisol and aldosterone production (Cushing's) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 17 alpha hydroxylase inhibitor--blocks all steroid synthesis (Cushing's disease) anti-fungal
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenocortical insufficiency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hypercortisolism/hyperadrenocorticism |  | 
        |  | 
        
        | Term 
 
        | deferoxamine mesylate (desferal) |  | Definition 
 | 
        |  |